Press Releases from AbboMax, Inc (1 total)
Genetic Disorders and Four Anti-LRP Antibodies Introduced by AbboMax
AbboMax, Inc. introduces four anti-LRP5 and LRP6 antibodies.
San Jose, CA, July 03, 2019 -- Genetic skeletal disorders make up one of the largest groups among rare inherited conditions.
Studies show that Wnt signaling is central to bone development and skeletal homeostasis. Its deregulation is associated with bone pathologies. LRP5 and LRP6 are a members of a family of the low-density-lipoprotein (LDLR). LRP5 is a key component of the co-receptor group…
